Y Chromosome Microdeletion Test in the UAE: What Male Infertility Investigations Often Miss

A consultant medical geneticist's clinical guide to AZF-region testing — why a normal semen analysis doesn't rule out a genetic cause of infertility, and what a microdeletion result means for a couple's next step, including for future sons.

What the AZF Region Actually Controls

The Y chromosome carries a segment called the azoospermia factor (AZF) region, divided into three sub-regions — AZFa, AZFb, and AZFc — each holding genes essential for different stages of sperm production (spermatogenesis). A microdeletion is a small, often microscopic loss of genetic material within one of these sub-regions. Unlike a karyotype, which visualizes whole chromosome structure, this test uses PCR-based molecular analysis to detect these small, targeted deletions that a standard chromosome analysis would miss entirely.

Clinically, where the deletion occurs matters as much as whether one exists:

Why This Test Deserves More Attention in UAE Fertility Workups

A large share of infertility evaluation in the region still centers on the female partner first, even though male-factor infertility contributes to roughly half of all infertility cases globally. In my consultations, I regularly see men referred late — often only after multiple failed IVF or ICSI cycles — for genetic testing that could have shaped the treatment plan from the outset. Given the UAE's high reliance on assisted reproduction and the cultural weight placed on family continuity, identifying a Y-linked genetic cause early changes both the clinical roadmap and the conversation a couple has about realistic outcomes.

There is also a generational dimension unique to this test. Because the Y chromosome passes intact from father to son, a man who conceives via ICSI using surgically retrieved sperm will pass the same microdeletion to any son he has. This is not a discussion that belongs on a lab test order form — it belongs in a genetic counseling session before treatment begins.

When This Test Is Clinically Indicated

• 1 Severe oligospermia — sperm concentration below approximately 5 million/mL on semen analysis
• 2 Non-obstructive azoospermia — absence of sperm in the ejaculate not explained by a blockage
• 3 Prior to surgical sperm retrieval procedures (TESE/micro-TESE), to help set realistic expectations on retrieval success
• 4 Prior to ICSI, where a father's Y-linked deletion carries direct implications for a future son
• 5 Unexplained male infertility with otherwise normal hormonal and anatomical evaluation

Y Microdeletion Testing vs. Karyotype: Different Questions, Same Workup

Patients often assume a karyotype already covers this. It doesn't. A karyotype detects whole-chromosome structural or numerical abnormalities, such as Klinefelter syndrome (47,XXY) — a separate and more common cause of male infertility. A Y chromosome microdeletion, by contrast, is far too small to see on a karyotype and requires targeted molecular analysis of specific AZF markers. In a thorough male infertility workup, I typically recommend both tests together rather than one in place of the other, since they identify entirely different genetic mechanisms.

What Happens After a Positive Result

A confirmed microdeletion moves the clinical conversation in one of a few directions, depending on which AZF region is involved: whether surgical sperm retrieval is realistically worth attempting, whether donor sperm should be discussed as an option, and — for couples proceeding with ICSI — how to counsel around the near-certain transmission of the deletion to a son. None of these are decisions a lab report makes on its own; they're worked through with a genetic counselor alongside the fertility specialist managing the couple's IVF or ICSI cycle.

Choosing the Right Panel Depth

Not every clinical picture requires the same level of molecular detail. A focused screen covering the core AZFa, AZFb, and AZFc markers is often sufficient for an initial infertility workup, while an expanded multi-marker panel can offer finer resolution on partial deletions or borderline cases. Which depth is appropriate is a decision best made with your treating physician based on your semen analysis and hormonal profile.

Frequently Asked Clinical Questions